BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31394022)

  • 1. The results of radiotherapy for squamous cell carcinomas of the skin.
    Soydemir GP; Kandaz M; Melikoğlu M
    Dermatol Ther; 2019 Sep; 32(5):e13058. PubMed ID: 31394022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus.
    Moon S; Kim H; Chie E; Kim J; Park C
    Dis Esophagus; 2009; 22(4):298-304. PubMed ID: 19021683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
    Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 squamous cell carcinoma of the glottis with anterior commissure involvement: Radiotherapy versus transoral laser microsurgery.
    Alkan U; Nachalon Y; Shkedy Y; Yaniv D; Shvero J; Popovtzer A
    Head Neck; 2017 Jun; 39(6):1101-1105. PubMed ID: 28371063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
    Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.
    Raza SM; Ramakrishna R; Weber RS; Kupferman ME; Gidley PW; Hanna EY; DeMonte F
    J Neurosurg; 2015 Sep; 123(3):781-8. PubMed ID: 25909577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
    Araki D; Redman MW; Martins R; Eaton K; Baik C; Chow L; Goulart B; Lee S; Santana-Davila R; Liao J; Parvathaneni U; Laramore G; Futran N; Mendez E; Bhrany A; Rodriguez CP
    Head Neck; 2016 Sep; 38(9):1318-23. PubMed ID: 27061333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
    Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
    Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
    Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.
    Dragovic AF; Bonner JA; Spencer SA; Nabell LM; Carroll WR; Caudell JJ
    Head Neck; 2011 Nov; 33(11):1551-6. PubMed ID: 21990218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy in Periocular Cutaneous Malignancies: A Retrospective Study.
    Lazarevic D; Ramelyte E; Dummer R; Imhof L
    Dermatology; 2019; 235(3):234-239. PubMed ID: 30939473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Kılıç S; Kılıç SS; Hsueh WD; Eloy JA; Baredes S; Woo Park RC; Mahmoud O
    Head Neck; 2018 Nov; 40(11):2441-2448. PubMed ID: 30306665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.